Empagliflozin Fails to Reduce Events After Acute MI
Empagliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, did not show significant benefit in reducing a first heart failure (HF) hospitalization ...
Empagliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, did not show significant benefit in reducing a first heart failure (HF) hospitalization ...
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage ...
A human apolipoprotein A1 (ApoA1) product, which is the key constituent of high-density lipoprotein (HDL) cholesterol and removes excess lipid ...
ATLANTA, GA — Despite promise for improving heart failure (HF) in pilot studies, an interarterial shunt (IAS) device did not ...
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine ...
Faustinella and Auerbach are internists. Gajewski is a medical student who will soon start residency in internal medicine. As the ...
A single round of prostate cancer screening that included a prostate-specific antigen (PSA) test, a kallikrein panel, and an MRI ...
© 2022 NewsHealth.
© 2022 NewsHealth.
1 2 3 4 5 6 7 8 1211 639 670 27 3510482 523172 487609 488680 502977